NIH’s Dr. Carl Dieffenbach Shares Highlights from First Day of CROI 2015 (Video)

Carl Dieffenbach - NIH - CROI2015

After the first full day of sessions at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  in Seattle yesterday, February 24, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…

Let’s Get to Work!

Multi-Ethnic Group of People in a Meeting and Copy Space

In October, I attended the annual U.S. Conference on AIDS , the largest HIV/AIDS-related gathering in the nation. Now in its eighteenth year, the goal of this conference has remained steadfast since the start: to increase and strengthen the diversity of the nation’s response to the HIV/AIDS epidemic through education, training and collaboration. What has evolved…

Revised Hepatitis C (HCV)/HIV Coinfection Section of the Adult and Adolescent Antiretroviral Treatment Guidelines Released

Last week, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announced the release of the updated “Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.” As described in What’s New in the Guidelines, this interim revision of the guidelines features a revised section on Hepatitis C (HCV)/HIV Coinfection that emphasizes…

Conversations in 2014: HIV Care and Treatment

Ron Valdiserri and Carl Dieffenbach

As partners around the world gear up for the annual observance of World AIDS Day on December 1, we at are taking a moment to look back on some of our 2014 blog posts that we thought were particularly important.  Today, we share some of our blogs about efforts to enhance the treatment and…

CDC and HRSA Announce Funding Opportunities for HIV Prevention and Care

CDC Logo

Both the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) recently announced funding opportunities for HIV services that may be of interest to readers of the blog. CDC Funding for High Impact HIV Prevention Programs for CBOs: Deadline November 14 CDC announced the availability of fiscal year 2015 funds…

A Prescription for Ending the HIV Epidemic


Antiretroviral treatment can enable HIV-infected Americans to avoid the debilitating illnesses and premature death once nearly inescapable for people with the infection. Research has shown that, when taken consistently, these medications also greatly reduce transmission of the virus to others. In other words, if everyone in the United States who is infected with HIV took antiretroviral therapy…

Gay and Bisexual Men See HIV as the Top Health Issue Facing Their Community, But Majorities Are Not Personally Worried About Getting Infected & Not Getting Tested Regularly


Most Are Unaware of New Prevention Options, Such as PrEP, or Current Treatment Recommendations MENLO PARK, CA – More than thirty years into the HIV/AIDS epidemic, and at a time when infections among gay and bisexual men are on the rise in the U.S., a new national survey  of gay and bisexual men by the Kaiser Family Foundation…

CDC’s New “HIV Treatment Works” Supports National Efforts to Improve Outcomes Along the HIV Care Continuum


Earlier this week, I had the privilege of participating in the launch of HIV Treatment Works, CDC’s first national communication campaign focused exclusively on encouraging treatment and care for people living with HIV. The campaign features people living with HIV talking about how sticking with care and treatment helps them stay healthy and protect others….